WATERTOWN, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that ...
Some results have been hidden because they may be inaccessible to you